Customers drawn to Zappy Health for affordable obesity treatments faced a harsh reality when they learned that their drugs were sourced from an unlicensed pharmacy, Ousia. The lack of a sterile compounding license raised serious safety concerns, particularly for injectable medications. Zappy Health terminated its relationship with Ousia after discovering the licensing breach, branding itself as a major victim of the oversight. Customers, like Laura Franzese, reported purchasing the drug without knowledge of these issues, leading to financial losses and potential health risks that have tainted Zappy’s reputation.
Laura Franzese, a customer, discovered Ousia’s licensing issue after spending $1,000 on tirzepatide from Zappy, only to see the problematic labels upon arrival.
Zappy’s founder stated they were the biggest victims, facing severe financial and reputational harm due to Ousia Pharmacy's licensing issues.
Collection
[
|
...
]